Results

According to the 2020 Federal Decree on the Horizon Package, SERI can directly fund researchers and innovators in Switzerland who have not received funding from the European Commission because Switzerland is not associated to the respective programmes (see Transitional Measures - Direct Funding). This applies to collaborative and mono-beneficiary projects.

Mono-beneficiary projects 2021

The proposals for the ERC Starting and Consolidator Grants as well as the EIC Accelerator of the 2021 calls were evaluated by the European Commission on an exceptional basis without Switzerland being associated to Horizon Europe. Therefore, SERI can award ‘SERI-funded ERC Starting Grants’, ‘SERI-funded ERC Consolidator Grants’ or ‘SERI funded-EIC Accelerator Grants’ (see Mono-beneficiary projects 2021). If they carry out their project in Switzerland, researchers and innovators with a successfully evaluated project receive direct funding from SERI.

SERI-funded EIC Accelerator Grants

‘SERI-funded EIC Accelerator Grants’ (listed below) are awarded for projects, which have been positively evaluated in the first EIC Accelerator cut-off 2021 (after two evaluation stages) and will be carried out in Switzerland. Funding by SERI should accelerate the market entry and growth of these companies. Their newly developed products shall contribute to addressing societal challenges.

Instrument
Acronym Full title Institution Direct funding by SERI (CHF)

SERI-funded EIC Accelerator Grants

OXYPREM

Preventing death and disabilities for preterm children

OxyPrem AG

2'205'005

Rapid-C

Automatic and real-time bio-contamination monitoring for the pharma industry, life sciences and beyond

Plair SA

2'727'653

SOFT ECoG

Soft & High-Resolution Neural Interfaces for Epilepsy Surgery Monitoring

Neurosoft Bioelectronics SA

2'557'071

NanoDrip

Revolutionary NanoDrip printing technology for semiconductor industrial scale manufacturing enabling the next generation of high-end devices

Scrona AG

2'659'254

VALORISE

High-Value Chemicals from Biomass through Lignin Stabilisation & Extraction

Bloom Biorenewables SA

2'734'975

Deasyl

Unlocking the world’s transition towards the production of sustainable 2nd generation Biodiesel

Deasyl SA

2'648'030

THEIA

Translucency & High Efficiency in Agrivoltaics

Insolight SA

2'734'360

Perovskite-QDD

The most cost-efficient quantum dot material technology for stunning colors and energy efficiency in QLED televisions

Avantama AG

2'059'026

Piomic

Kickstarting chronic wound healing

Piomic Medical AG

2'734'975

Miraex

Photonic Sensing Solutions For Extreme Environments

Miraex SA

2'734'360

Oxara

An admixture technology as materials solution for sustainable and affordable housing

OXARA AG

1'868'172

SmartGUIDE

A breakthrough smart guidewire device for a fast and reliable stroke treatment that will save lives

Artiria Medical SA

2'698'482

LMtrace

Revolutionizing drug discovery for neurological diseases by combining human and artificial intelligence

Ariadne.ai AG

2'203'947

NAGI

“Worm-on-chip”: in vivo testing at the in vitro scale

Nagi Bioscience SA

2'718'219

CycloPlast

The first PET plastic depolymerisation recycling technology to recover 99% of PET materials for the first truly circular plastics economy

DePoly SA

2'716'049

Coacillium

The world first broad-spectrum drug for treating Alopecia associated to autoimmune conditions

Legacy Healthcare (Switzerland) SA

2'692'854

ProRange

Energy-conscious autonomous driving software

embotechAG

564'585

SaneMembrane

Non-harmful membranes enabling a sustainable circular economy

dimpora AG

1'852'125

KOVE

Saving babies before they are born

KOVE medical AG

2'106'888

INFERREO

Integrated Ferroelectric Electro-Optical Chips

Lumiphase AG

2'734'975

PROTEUSQ

Nanometric Quantum Metrology: Enabling the future of computing

Qnami AG

2'734'975

ATCC

Ecofriendly, cost-competitive and energy self-sustaining temperature-controlled container for the air transport of temperature-sensitive pharma products

Swiss Airtainer SA

2'734'975

CuTrace

Novel, broadly available PET tracers for personalised cancer diagnostics

Nuclidium AG

2'409'376

cPET

Turning unrecyclable plastic waste PET into 100% virgin material for a full circular economy

gr3n SA

2'465'567

https://www.sbfi.admin.ch/content/sbfi/en/home/research-and-innovation/international-cooperation-r-and-i/eu-framework-programmes-for-research/horizon-europe/transitional-measures/results.html